10-K: Xenous Holdings Reports Deepening Deficit and Going Concern Doubts Amid Protracted Acquisition Pursuit

Xenous Holdings, a non-operational shell company, reported increased net losses and a growing working capital deficit for the fiscal year ended March 31, 2025, as it continues its protracted evaluation of a potential acquisition target, Dadvance Agarwood Alpha Sdn Bhd.

Summary

• Xenous Holdings, Inc. is a non-operational shell company actively seeking and investigating potential assets, property, or businesses for acquisition or merger.
• For the fiscal year ended March 31, 2025, the company reported a net loss of $64,456, an increase from $63,746 in the prior year.
• Operating expenses increased slightly to $64,456 in 2025 from $63,746 in 2024, primarily due to higher professional fees.
• The company has no current assets and a working capital deficit of $903,622 as of March 31, 2025, up from $839,166 in 2024.
• Total liabilities stood at $903,622 as of March 31, 2025, with a stockholders' deficit of the same amount.
• The accumulated deficit reached $1,214,422 as of March 31, 2025.
• Net cash used in operating activities was $63,637 for the year ended March 31, 2025, entirely offset by cash provided by financing activities from related party advances.
• The company's independent auditors have raised substantial doubt about its ability to continue as a going concern due to its lack of revenue, net losses, nominal assets, and stockholders' deficit.
• Xenous is dependent on advances from its majority shareholder, Smartex Investment Ltd., for continued funding, with no commitments or guarantees for future financing.
• The company is continuing its evaluation of Dadvance Agarwood Alpha Sdn Bhd for a potential acquisition, with preliminary due diligence completed and further focus on intangible assets and valuation.
• Dadvance has shown progress in market penetration (Europe, Gulf Arab markets), product quality recognition (A+ grade agarwood oil), and production scale-up initiatives.

Sentiment

Score: 2

Explanation: The company is a non-operational shell with increasing losses, a deepening deficit, and a going concern warning. While there's ongoing due diligence for a potential acquisition, it's protracted and contingent, offering no immediate financial relief or operational certainty. The ineffective disclosure controls add to the negative sentiment.

Positives

• Preliminary due diligence for the Dadvance Agarwood Alpha Sdn Bhd acquisition target has been successfully completed, confirming confidence in its potential value.
• Dadvance has made notable progress in expanding its presence in European and Gulf Arab markets, establishing preliminary sales and distribution arrangements.
• Dadvance's agarwood oil has received A+ grade certification from the Bioaromatic Research Centre of Universiti Malaysia Pahang, affirming its premium quality.
• Dadvance has commenced phased installation of new distillation units to scale production capacity in anticipation of increased demand.
• Exploratory initiatives are underway by Dadvance to develop a proprietary consumer brand aimed at the wellness and luxury aromatherapy market segment.

Negatives

• The company has no current business operations and has not generated any revenue since its inception.
• Xenous Holdings incurred a net loss of $64,456 for the fiscal year ended March 31, 2025, an increase from the prior year.
• The company has no assets as of March 31, 2025, and a significant working capital deficit of $903,622.
• A stockholders' deficit of $903,622 and an accumulated deficit of $1,214,422 indicate severe financial distress.
• The independent auditors have expressed substantial doubt about the company's ability to continue as a going concern.
• The company is entirely dependent on non-interest bearing, due-on-demand advances from its majority shareholder for funding, with no external commitments or guarantees.
• Disclosure controls and procedures were evaluated as not effective as of March 31, 2025, raising concerns about financial reporting reliability.
• A substantial number of common shares (707,050,000) are restricted from resale under Rule 144 until at least one year after a merger or business operations commence and an 8-K is filed, potentially depressing any future market.
• The company has no employees, products, services, or established distribution methods.

Risks

• Going Concern Risk: Substantial doubt exists about the company's ability to continue as a going concern due to lack of revenue, net losses, nominal assets, and a significant stockholders' deficit.
• Funding Dependency: Continuation of operations is entirely dependent on advances from the principal shareholder, with no guarantees of continued funding.
• Acquisition Uncertainty: There is no assurance that the company will be able to identify and acquire a business opportunity that will prove beneficial, or that the Dadvance acquisition will be finalized.
• Regulatory Hurdles for Shell Companies: SEC amendments to Form 8-K and Rule 144 limit the perceived advantages of 'going public' via reverse reorganizations for shell companies, restricting resale of securities and use of Form S-8.
• Dilution Risk: Any successful acquisition or merger will likely require the issuance of a substantial number of common shares, resulting in significant dilution to current shareholders.
• Competitive Disadvantage: The company, with limited assets and no cash reserves, is at a competitive disadvantage compared to other shell companies or publicly-held entities with significant resources.
• Lack of Audited Financials for Targets: Potential target businesses may not have audited financial statements, limiting acquisition opportunities due to SEC requirements.
• Cybersecurity Risk: Very limited IT systems and cybersecurity measures are in place, posing a risk of cyber-attacks or data breaches.
• Market for Common Stock: No established trading market exists for the common stock, and management does not expect one to develop until an acquisition or merger is completed.
• Resale Limitations: A large portion of outstanding shares (707,050,000) are restricted from resale under Rule 144, which could depress any future market when they become available.
• Conflict of Interest: Potential finders' fees or compensation to management/principal stockholders in the form of shares could present conflicts of interest and further dilute existing shareholders.
• Internal Control Deficiencies: Disclosure controls and procedures were deemed not effective, indicating a risk in the accuracy and timeliness of financial reporting.

Future Outlook

Xenous Holdings plans for the next 12 months include considering industry guidelines, adopting a business plan for a selected industry, and commencing operations through funding or acquisition of a going concern. The company is unable to predict the exact timing of participation in any specific business endeavor. The final decision on the Dadvance acquisition is contingent upon converting strategic leads into long-term contracts, confirming supply chain scalability, completing comprehensive market feasibility studies, and receiving an independent fairness opinion. The final phase of due diligence for Dadvance is expected to be completed by the first half of calendar year 2025, after which the acquisition will formally proceed.

Management Comments

• "We are currently seeking and investigating potential assets, property or businesses to acquire."
• "We currently have no material business operations."
• "Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a going concern engaged in any industry selected."
• "The Company continues to closely monitor Dadvance's operational growth, market engagement, and product acceptance in key international markets, particularly in the Middle East, Europe, and Southeast Asia."
• "The Board of Directors continues to regard Dadvance as a promising target aligned with the Company's diversification and growth strategy. However, consistent with the Company's prudent approach to capital allocation and risk management, no definitive agreement will be executed unless the commercial case is conclusively validated."
• "The Company will issue further updates as the evaluation advances or upon the occurrence of any material developments."
• "Management does not expect any viable market to develop in our common stock unless and until we complete an acquisition or merger."
• "While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect."

Industry Context

Xenous Holdings operates as a non-operational shell company, a common vehicle for private entities seeking to go public via reverse merger or acquisition, often to bypass the complexities and costs of a traditional IPO. The company's pursuit of Dadvance Agarwood Alpha Sdn Bhd indicates a strategic interest in the agarwood industry, which involves cultivation, processing, and marketing of a high-value aromatic wood used in fragrances, traditional medicine, and luxury goods. This move aligns with a broader trend of diversification for shell companies into niche or emerging markets. However, the regulatory environment for shell companies has become more stringent, with SEC amendments limiting the benefits of such transactions, which could impact Xenous's ability to attract suitable acquisition targets and provide liquidity for its shareholders. The company's lack of internal resources and reliance on related-party funding places it at a significant disadvantage compared to more established entities or better-capitalized shell companies.

Comparison to Industry Standards

• As a non-operational shell company, Xenous Holdings does not have comparable business operations, products, or services to benchmark against industry standards for operating companies.
• Compared to other shell companies, Xenous is at a competitive disadvantage due to its limited assets and no cash reserves, whereas many competitors have substantial current assets and cash.
• The company's financial position, characterized by zero revenue, consistent net losses, and a growing working capital and stockholders' deficit, is significantly below any industry standard for a viable operating business.
• The reliance on related-party advances for all operational funding is a common characteristic of distressed or pre-revenue shell companies, but it highlights a lack of independent financial viability.
• The ongoing, protracted due diligence for the Dadvance acquisition, while showing some progress for Dadvance itself (e.g., A+ grade certification, market penetration), is still in a non-binding phase, which is typical for high-risk, early-stage acquisition targets for shell companies.

Management Changes

Corporate Governance

Related Party Transactions

• Smartex Investment Ltd., the majority shareholder (82% common shares), advanced $63,637 to the company for operating expenses during the year ended March 31, 2025.
• Smartex Investment Ltd. advanced $54,627 to the company for operating expenses during the year ended March 31, 2024.
• As of March 31, 2025, the total amount due to Smartex Investment Ltd. was $879,718.
• As of March 31, 2024, the total amount due to Smartex Investment Ltd. was $816,081.
• The loans from Smartex Investment Ltd. are non-interest bearing and due on demand.

Stakeholder Impact

• Shareholders: Face significant dilution risk from future share issuances for acquisitions or management compensation. A large portion of shares are restricted from resale, limiting liquidity. The lack of an established trading market and the going concern warning pose substantial risks to investment value.
• Employees: Currently, there are no employees, so no direct impact. Future employees of an acquired entity would become subject to the company's reporting requirements and potential stock option plan limitations.
• Customers: Currently, there are no customers for Xenous Holdings. Potential future customers of an acquired entity (like Dadvance) would benefit from product quality and market expansion.
• Suppliers: Currently, there are no direct suppliers for Xenous Holdings. Future suppliers of an acquired entity would be impacted by the acquired entity's operational stability and payment capabilities.
• Creditors: The primary creditor is the majority shareholder, Smartex Investment Ltd., which has provided non-interest bearing, due-on-demand advances. Other creditors (e.g., for professional fees) face risk due to the company's severe working capital deficit and going concern issues.

Next Steps

• Consider guidelines of industries for potential interest.
• Adopt a business plan for a selected industry.
• Commence operations through funding and/or acquisition of a going concern.
• Complete further due diligence on Dadvance Agarwood Alpha Sdn Bhd, focusing on intangible assets and valuation.
• Convert strategic leads for Dadvance into long-term, revenue-generating contracts.
• Confirm supply chain scalability and fulfillment capabilities for Dadvance.
• Complete comprehensive market feasibility studies for Dadvance, particularly in core target regions.
• Receive an independent fairness opinion confirming the Dadvance acquisition's value and fairness.
• Formally proceed with the Dadvance acquisition following the successful conclusion of the final due diligence phase (expected by H1 2025).
• Issue further updates on the Dadvance evaluation or any material developments.
• Review the need for a Nominating Committee and Audit Committee after entering into a business or completing an acquisition/merger.

Key Dates

Recommendation

Keywords

Xenous Holdings, XITO, 10-K, Annual Report, Shell Company, Acquisition Target, Dadvance Agarwood Alpha, Agarwood Industry, Financial Deficit, Going Concern, Related Party Transactions, OTC Pink Sheets, Corporate Governance, SEC Filings, Financial Reporting, Risk Management, Strategic Acquisition